Ryvu Therapeutics SA engages in the provision of products and solutions for the pharmaceutical and biotechnology industry. It operates through the following segments: Innovation, Services, and Bioinformatics. The Innovation segment focuses on the small-molecule marketing activities of the pharmacological action, which is the next stage of the process of developing the commercialization process. The Services segment provides services for the contracting department. Its projects and services include contract chemistry services; biology services; integrated drug discovery projects; and comparative studies of biosimilar medicinal products. The company was founded by Boguslaw Sieczkowski and Pawel Przewiezlikowski in 2007 and is headquartered in Krakow, Poland.